BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Policy

  Merck & Co., Inc. to Pay Over $650M to Settle US Drug Pricing Probe

  February 7, 2008

   · 

  1 min read
• Genetown

  Oscient Pharmaceuticals Corporation to Participate in the Biotechnology Industry Organization (BIO) CEO & Investor Conference

  February 7, 2008

   · 

  1 min read
• Business

  Human Genome Sciences, Inc. and Xencor Announce Antibody Collaboration

  February 7, 2008

   · 

  6 min read
• Policy

  FDA Advisory Committee Supports Efficacy and Safety of Eli Lilly and Company’s Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

  February 7, 2008

   · 

  8 min read
• Drug Development

  Chelsea Therapeutics, Inc. Begins Patient Dosing in Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension

  February 7, 2008

   · 

  1 min read
• Business

  CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters

  February 7, 2008

   · 

  1 min read
• Policy

  Ranbaxy Laboratories Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules

  February 7, 2008

   · 

  1 min read
• Drug Development

  Alnylam Pharmaceuticals Reports Pre-clinical Progress with RNAi Therapeutics in Neurological Disease

  February 7, 2008

   · 

  1 min read
• Business

  Angeion Corporation Appoints Paula Skjefte to Board of Directors

  February 7, 2008

   · 

  1 min read
• Business

  YM BioSciences Reports Second Quarter 2008 Operational And Financial Results

  February 7, 2008

   · 

  1 min read